REYNOLDS CAMERON JOHN (President and CEO) purchased 0.6% of their position (10K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $6.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/11/2023ACC: 0001477932-23-009055
DirectorOfficer· President and CEO
+10K
Net shares
Net buyer
$6.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.67
Trade value
$6.70K
% of position
0.6%
—
1.69M→1.70M
Total
Net shares
+10K
Net value
$6.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +10K | $0.67 | $6.70K | 0.6% | 1.69M | 1.70M |
| Total | +10K | $6.70K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned34.08K
Total
1.04M indirect1.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 34.08K | Indirect |
| Total | 1.04M | 1.04M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported